SupplyChainBrain February 24, 2020
Karen Conway, SCB Contributor

There’s no shortage of enthusiasm — or predictions — about the potential use of artificial intelligence (AI).

Grand View Research estimates the global AI market will grow at a compound annual rate of 57% between 2017 and 2025, reaching $36 billion. Forrester predicts that 2020 is the year executives will focus on how to drive and measure the value of their investments in AI.

Healthcare is no exception. A recent survey of healthcare executives conducted by Optum found that not only is use of AI on the rise, but also that most executives expect a faster return on their investments than first anticipated.

What’s missing from these lofty projections are more substantive discussions about what’s required to ensure that AI...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Supply Chain, Technology
Amazon Business helps evolve the traditional supply chain
HHS floats hospital pay incentives to strengthen drug supply
AstraZeneca plans independent drug supply chains for US and China, CEO says
Vitality in the Supply Chain: The Limitless Potential of ATMPs
Red Sea Shipping Disruptions Don’t Have Pharma Companies Seeing Red Just Yet

Share This Article